Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.14241
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 22, 2020
Authors
Publisher
Wiley